Our Team Has 80Years Of Combined Experienceutilizing Ophthalmic Animal Models For Drug Developmentwespecializein Preclinical Ophthalmic Studies Of Pharmacology Efficacypk Toxand Eyedrop Formulation Development Efficacy Models Includedry Eyeallergic Conjunctivitislaser Induced Choroidal Neovascularizationstz Induced Diabetesischemia Reperfusioninherited Retinal Degenerationsoptic Nervecrushlight Induced Retinal Degenerationgeographic Atrophyretinal Vascular Leakageoxygen Induced Retinopathycorneal Neovascularizationglaucomaexperimental Autoimmuneuveitisand Lc Ms Quantification Of A2Epropietary Midropsa C Technology Is Also Availableto Formulatesmall Lipohilic Molecules For Topical Instillationeyedropthis Patented Technology Platform Can Producestableand Safeformulations That Deliver Largeamounts Of Drug Into Theeye
No conferences found for this company.
| Company Name | Eyecro Llc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
